Meghmani Organics Ltd Slides to All-Time Low Amidst Prolonged Downtrend

Price Action and Market Performance

On 23 Mar 2026, Meghmani Organics Ltd closed at Rs 41.15, just 0.55% above its 52-week low of Rs 41.27. The stock underperformed its sector by 0.83% and the broader Sensex by 1.6%, continuing a bearish trend that has persisted since mid-November 2025 when the price was above Rs 72. The share price has declined by 36.81% over the last three months, significantly worse than the Sensex’s 14.28% fall during the same period. Over three years, the stock has lost more than half its value, contrasting sharply with the Sensex’s 26.56% gain.

The technical indicators reinforce this downtrend. The stock trades below all key moving averages (5, 20, 50, 100, and 200 days), with the MACD and Bollinger Bands signalling bearish momentum on both weekly and monthly charts. The immediate support level is at Rs 41.27, while resistance lies at Rs 47.29, near the 20-day moving average. Delivery volumes have increased by over 56% in the past month, suggesting heightened trading activity amid the sell-off. What is driving such persistent weakness in Meghmani Organics when the broader market is in rally mode?

Valuation Metrics Highlight a Complex Picture

Despite the share price slump, valuation ratios present a mixed scenario. The price-to-earnings (P/E) ratio stands at 27x, which is moderate but not excessively high given the sector. The price-to-book value (P/BV) is 0.70x, indicating the stock is trading below its book value, often a sign of undervaluation. Enterprise value to EBITDA is 8.47x, and EV to capital employed is a low 0.80x, suggesting the market values the company’s capital base conservatively. The PEG ratio is particularly low at 0.15x, reflecting the stock’s depressed price relative to earnings growth.

However, the dividend yield is not available, and the last dividend was Rs 1.4 per share paid in June 2023. The stock’s valuation is also weighed down by a 61% fall from its 52-week high of Rs 106.03. Should you be looking at Meghmani Organics as a potential entry point or is there more downside ahead?

Quarterly Financial Trends Reveal Mixed Signals

The latest quarterly results show a sharp decline in profitability, with a net loss after tax (PAT) of Rs -3.53 crores, a 135.6% fall compared to the previous four-quarter average. Net sales also dropped by 12% to Rs 508.74 crores in the quarter. Meanwhile, interest expenses have increased by 22.18% over nine months, reaching Rs 71.38 crores, putting additional pressure on earnings. Operating profit to interest coverage ratio has fallen to a low of 2.08 times, signalling tighter financial flexibility.

Interestingly, the company’s profit after tax for the last six months has grown by 158.71% to Rs 8.02 crores, and the half-year ROCE is at its highest at 7.30%. Yet, the quarterly PBT excluding non-operating income is negative at Rs -10.33 crores, with non-operating income accounting for over 329% of PBT, indicating that core business profitability remains under strain. Is this quarterly weakness a temporary setback or a sign of deeper issues?

Quality and Capital Structure Considerations

Meghmani Organics Ltd is classified as a below-average quality company based on long-term financial performance. Its five-year sales growth is modest at 1.18%, while EBIT has contracted at a CAGR of -17.31%. The average EBIT to interest ratio is negative at -5.58x, reflecting challenges in covering interest costs from operating earnings. The company maintains a low debt-to-EBITDA ratio of 0.93 and moderate net debt to equity of 0.52, indicating manageable leverage levels.

Return on capital employed (ROCE) averages 7.62%, and return on equity (ROE) is weak at 6.03%, suggesting limited profitability relative to invested capital and shareholders’ funds. Institutional holding is low at 1.38%, and there is no promoter share pledging, which may be viewed positively from a governance perspective. How much weight should investors place on these quality metrics amid the ongoing price decline?

Key Data at a Glance

Balancing the Bear Case and Potential Silver Linings

The prolonged decline in Meghmani Organics Ltd shares is underpinned by weak long-term fundamentals, including a negative CAGR of -17.31% in operating profits over five years and a poor EBIT to interest coverage ratio. The company’s ability to generate returns on equity and capital employed remains subdued, and quarterly results show recent sales and profit contractions alongside rising interest costs.

Yet, the valuation metrics suggest the stock is trading at a discount relative to its capital base and earnings growth, with a PEG ratio of 0.15x and a P/BV below 1. The absence of promoter pledging and a strong balance sheet provide some reassurance. The divergence between improving half-year PAT growth and the share price slide highlights a complex investment case. Should you buy, sell, or hold at these levels? Explore the complete multi-factor analysis of Meghmani Organics Ltd to find out what the data signals at this all-time low.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →